Position in SCYX
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$26,450
+$4,294 QoQ
Shares Held
3,606
-17.7% QoQ
Ownership
0.036%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SCYX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Bank of New York Mellon Corp holds $1,289,702,180 across 44 Drug Manufacturers - Specialty & Generic names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,322,319 | $238,741,833 | |
| 2 | VTRS |
Viatris Inc
|
14,288,053 | $226,894,274 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
294,413 | $159,521,790 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
699,125 | $117,830,519 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
3,411,532 | $83,957,795 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
1,899,912 | $64,369,013 | |
| 7 | ALKS |
Alkermes plc.
|
1,097,282 | $57,497,573 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
441,831 | $49,016,724 |
All Filings in SCYX
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $26,450 | 28,846 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $22,156 | 35,059 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $26,994 | 35,059 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $23,664 | 35,059 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $33,374 | 35,059 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $42,420 | 35,059 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $52,237 | 35,059 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $70,118 | 35,059 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $51,535 | 35,058 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $90,441 | 40,557 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $92,469 | 40,557 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $119,643 | 40,557 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $121,671 | 40,557 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $63,268 | 40,557 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $97,336 | 40,557 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $75,435 | 40,557 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $158,577 | 40,557 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $247,397 | 40,557 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $214,952 | 40,557 | Shares | Defined | 2021-11-18 | |
| No filing history on record for this holder in this stock. | ||||||